New research from our team: Blood biomarkers like VEGF-D + Cystatin C or NGAL can accurately detect large renal angiomyolipomas in #TSC!
📄 Read the full study: https://t.co/Ij701sIWVv.
Une soirée mémorable chez Dr Evoy, où nous avons célébré la réussite de nos finissants R5 : Dr William Leduc, Dre Maude Lantagne-Hurtubise et Dr Thomas-Louis Perron. Félicitations à vous trois pour cette belle étape franchie ! 🥳🎊✨
Up to 15% of people with #TSC lack an identifiable genetic mutation. Our new study shows that assessing brain & skin manifestations is highly sensitive (98.7%) for diagnosing TSC in family members. https://t.co/LyD25SqmJC
Mirrored self-misidentification syndrome (MSMS) is a rare delusional disorder where patients don’t recognize their own reflection. Most cases occur in dementia (Alzheimer’s, Lewy Body, vascular dementia). Read our systematic review here: https://t.co/A5kgK2Yz4E. 🪞
I'm spending a good amount of time this year analysing grey publishers. In this little piece I re-analysed some great data from @neuroloJimmy and colleagues. It's not often I see work in this space showing Frontiers to be the more extreme of the two: https://t.co/FptuudOpS1
Case report: a man who tested positive for IgLON5-IgG antibody after intermittent episodes of paresthetic feeling involving the throat and jaw.
https://t.co/BfT8ao0BXH
Honored to receive a Resident Scholarship Award at this 2025 AAN Annual Meeting. I can't believe we're already the before-last day! Thank you so much #AANAM; San Diego is such an awesome city. ☀️
On Purple Day (@PurpleDay ), we show our support to all people with epilepsy. I feel truly blessed to be able to follow and support these patients. You are my heroes! 💜
Intracranial dural arteriovenous fistulas (DAVFs) are a rare but treatable cause of seizures. Our systematic review highlights key clinical features, diagnosis, and management of DAVF-related seizures. Read more: https://t.co/JjZGdqobXf. 📖
🚨 Our team shows in @GreenJournal that people with epilepsy using sodium channel blocker ASMs have higher odds of cardiac conduction delays, while epilepsy itself is not a risk factor. Read more here 👉 https://t.co/1b8hfojrnt. Good work @NathanShlobin!
New research sheds light on cognitive function in TSC. 🚨 Our study found that objective tests like the SDMT can uncover neurocognitive deficits often missed in self-reports, emphasizing the need for more thorough screening in TSC patients. Read more: https://t.co/pNXxiq2tZz.
We are delighted to share an important piece of work that compares the safety and efficacy of antiseizure medications relevant to post-stroke seizure patients that just appeared in the @GreenJournal . #stroke#epilepsy@IPSERC_@YaleMed@NeurologyYale
https://t.co/ClLvACeVax
In our latest study @EpilepsiaJourn, we uncover inflammatory markers linked to epilepsy in TSC, highlighting potential biomarkers and therapeutic targets. Could this pave the way for improved care in TSC? Read more: https://t.co/N9xFqAagIR.
UdeS proudly represented by Jean-Simon Dallaire (R3) at the 35th International Symposium on ALS/MMN in Montreal 🤩🧠
His presentation focuses on complications and mortality related to gastrostomy placement in patients with ALS. Congratulations! 🙌🏼✨